An experimental approach for the study of psychotropic drug effects under simulated clinical conditions

Current Drug Metabolism

Volumn 9, Issue 4, 2008, Pages 352-360

  Kudryavtseva, N N ^a   Avgustinovich, D F ^a   Bondar, N P ^a   Tenditnik, M V ^a   Kovalenko, I L ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Psychotropic drugs; Screening; Sensory contact model

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BUSPIRONE; CITALOPRAM; DIAZEPAM; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FLESINOXANE; FLUOGLYZINE; FLUOXETINE; FLUPENTIXOL; HALOPERIDOL; IMIPRAMINE; IPSAPIRONE; LITHIUM; NALTREXONE; NOOLIT; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN 1 AGONIST; SULPIRIDE; TIANEPTINE;

ACUTE PSYCHOSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG MEGADOSE; EMOTIONAL DISORDER; EXPERIMENTAL STUDY; EXPLORATORY BEHAVIOR; LONG TERM CARE; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PARTITION TEST; PASSIVE AVOIDANCE; PORSOLT TEST; PSYCHOLOGIC TEST; REVIEW; SHORT COURSE THERAPY; SOCIAL BEHAVIOR; SOCIAL STRESS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AFFECTIVE SYMPTOMS; ANIMALS; BEHAVIOR, ANIMAL; EMOTIONS; MENTAL DISORDERS; MICE; MODELS, PSYCHOLOGICAL; NEUROPROTECTIVE AGENTS; PSYCHOTROPIC DRUGS;

EID: 45249106341     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008784220592     Document Type: Review

References (89)

1. Kudryavtseva, N.N. (1991) Aggress. Behav., 17(5), 285-291.
2. Kudryavtseva, N.N.; Bakshtanovskaya, I.V. and Koryakina L.A. (1991) Pharmacol. Biochem. Behav., 38(2), 315-320.
3. Kudryavtseva, N.N. (2000) Neurosci. Behav. Physiol., 30, 293-305.
4. Kudryavtseva, N.N. (2000) Aggress. Behav., 26(3), 241-256.
5. Kudryavtseva, N.N. (2006) in Perspectives on the Psychology of Aggression, (Morgan, J..P. Ed) NOVA Science Publishers, Inc. 2006. pp. 35-64.
6. Avgustinovich, D.F.; Alekseenko, O.V.; Bakshtanovskaia, I.V.; Koryakina, L.A.; Lipina, T.V.; Tenditnik, M.V.; Bondar, N.P.; Kovalenko, I.L. and Kudryavtseva, N.N. (2004) Usp Fizziol Nauk., 35(4), 19-40.
7. Kudryavtseva, N.N.; Bakshtanovskaya, I.V.; Avgustinovich, D.F.; Koryakina, L.A.; Serova, L.I.; Wishnivetskaya, G.B.; Kaledin, V.I.; Popova, N.A.; Ilnitskaya, I.I.; Kolesnikova, L.A.; Amstislavskaya, T.G.; Gorbach, O.V.; Lipina, T.V.; Shigantsov, S.N., Madorskaya, I.A. and Denisova, T.P., (1995) Social defeats, depression and anxiety: an experimental model. Novosibirsk; Institute of Cytology and Genetics SD RAS, pp. 1-48.
8. Kudryavtseva, N.N. and Avgustinovich, D.F. (1998) Aggress. Behav., 24, 271-286.
9. Kudryavtseva, N.N.; Avgustinovich, D.F.; Bakshtanovskaya, I.V.; Koryakina, L.A.; Alekseyenko, O.V.; Lipina, T.V. and Bondar, N.P. (2006) in Animal Models of Biological Psychiatry (Kalueff, A.V. Ed,) Nova Science Publishers, Inc., New York, Chapter 5. pp. 75-95.
10. Kudryavtseva, N.N.; Avgustinovich, D.F.; Bondar, N.P.; Tenditnik, M.V. and Kovalenko, I.L. Method for screening drugs with supposed psychotropic actions. Patent: RU2006140591, 20061 1116, Inventor: Institute of Cytology and Genetics. 2007
11. McKinney, W.T.J. and Bunney, W.E.J. (1969) Arch. Gen. Psychiatry, 21, 240-248.
12. Cryan, J.F. and Mombereau, C. (2004) Mol. Psychiatry, 9, 326-357.
13. Kudryavtseva, N.N. and Bakshtanovskaya, I.V. (1989) Behav. Process., 20, 139-149.
14. Lipina, T.V.; Mikhnevich, N.V. and Kudriavtseva N.N. (2003) I.P. Pavlov J. Higher Nerv. Activity, 53(1), 88-93.
15. Avgustinovich, D.F.; Gorbach, O.V. and Kudryavtseva, N.N. (1997) Physiol. Behav., 61(1), 37-43.
16. Borodin, Ju.I.; Kudryavtseva, N.N.; Tenditnik, M.V.; Rachkovskaya, L.N.; Shurlygina, A.V. and Trufakin, V.A. (2002) Pharmacol. Biochem. Behav., 72, 131-141.
17. Dubrovina, N.I. (2001) Rus. J. Physiol., 87(8), 1126-1134.
18. Dubrovina, N.I.; Popova, E.V. and Il'iuchenok, R.Iu. (1997) I.P. Pavlov J. Higher Nerv. Activity, 47(4), 762-765.
19. Il'iuchenok, R.Iu.; Dubrovina, N.I. and Popova, E.V. (2001) I.P. Pavlov J. Higher Nerv. Activity, 51(4) 467-472.
20. Lipina, T.V. and Kudryavtseva N.N. (2008) I.P. Pavlov J. Higher Nerv. Activity, 58(1), 75-62.
21. Kudryavtseva, N.N.; Madorskaya, I.A. and Bakshtanovskaya, I.V. (1991) Physiol. Behav., 50(1), 143-146.
22. Kudryavtseva, N.; Gerrits M.A.; Avgustinovich, D.F.; Tenditnik, M.V. and Van Ree, (2006) Eur. Neuropsychopharmacol., 16(7), 504-511.
23. Kudryavtseva, N. N.; Bondar, N.P.; Kovalenko, I.L. and Avgustinovich, D. F. (2007) Available from Nature Precedings. http://hdl.nature.com/10101/ npre.2007.988.1.
24. Bondar N.P.; Kovalenko I.L.; Avgustinovich, D.F. and Kudryavtseva N.N. (2008) I.P. Pavlov J. Higher Nerv. Activity, 58(1), 91-99
25. Kudriavtseva N.N.; Bakshtanovskaia I.V. and Popova N.K. (1989) L.P. Pavlov J. Higher Nerv. Activity, 39(1), 128-136.
26. Kulikov, A.V.; Kozlachkova, E.Y.; Kudryavtseva, N.N. and Popova, N.K. (1995) Pharmacol. Biochem. Behav., 50(3), 431-435.
27. Kudryavtseva N.N. (1994) Behav. Process., 32, 297-304.
28. Berton, O.; McClung, C.A.; DiLeone, R.J.,; Krishnan, V.; Rentha,l W.; Russo, S.J.; Graham, D.; Tsankova, N,M.; Bolanos, C.A.; Rios, M.; Monteggia, L.M.; Self, D.W. and Nestler, E.J. (2006) Science, 311, 864-868.
29. Kaledin, V.I.; Kudriavtseva, M.N. and Bakshtanovskaia, I.V. (1993) Dokl. Akad. Nauk, 329(1), 100-102.
30. Amikishieva, A.V. and Ovsyukova, M.V. (2003) Bull. Exp. Biol. Med., 136 (6), 607-610.
31. Devoino, L.; Alperina, E.; Kudryavtseva, N. and Popova, N. (1993) Brain Behav. Immun., 7(1), 91-96.
32. Gryazeva, N.J.; Shurlygina, A.V.; Verbitskaia, L.V.; Mel'nikova, E.V.; Kudryavtseva, N.N., and Trufakin, V.A. (2001) Neurosci. Behav. Physiol., 31(3), 75-81.
33. Tenditnik, M.V.; Shurlygina, A.V.; Mel'nikova, E.V.; Kudryavtseva, N.N. and Trufakin, V.A. (2004) Rus. J. Physiol., 90(12), 1522-1529.
34. Kaledin, V.I., Tenditnik, M.V.; Nikolin, V.P.; Popova, N.A.; Kudryavtseva N.N. (2006) Dokl. Biol. Sci., 406, 57-59.
35. Kudryavtseva, N.N.; Bondar, N.P. and Avgustinovich, D.F. (2002) Behav. Brain Res., 133, 83-93.
36. Bondar, N.P. Development of anxiety under forming of the learned aggression in C57BL/6J and CBA/Lac male mice: effects of anxiolitics. PhD. Thesis, 2005, 163 p.
37. Kudryavtseva, N.N.; Bakshtanovskaia, I.V. and Avgustinovich, D.F. (1997) I.P. Pavlov J. Higher Nerv., 47(1), 86-97.
38. Bondar, N.P. and Kudriavtseva, N.N. (2005) I.P. Pavlov J. Higher Nerv., 55(3), 378-384.
39. Kudryavtseva, N.N. in Motivation of Health Behavior. O'Neal, P.W. Ed. NOVA Science Publishers, Inc. 2007. Chapter 7, pp. 97-110.
40. Bondar, N.P. and Kudryavtseva, N.N. (2003) Rus. J. Physiol., 89(8), 992-1000.
41. Kudryavtseva, N.N.; Amstislavskaya, T.G. and Kucheryavy, S. (2004) Hormon. Behav., 45, 103-107.
42. Kudryavtseva, N.N.; Bondar, N.P. and Alekseyenko O.V. (2000) Aggress. Behav., 26(5), 386-400.
43. Avgustinovich, D.F.; Kovalenko, I.L. and Bondar, N.P. (2005) Rus. J. Physiol., 91(12), 1454-1468.
44. Pellow, S. and File, S.E. (1986) Pharmacol. Biochem. Behav., 24(3), 525-529.
45. Lister, R.G. (1987) Psychopharmacology (Berl)., 92(2), 180-185.
46. Porsolt, R.D.; Le Pichon M. and Jalfre M. (1977) Nature, 266, 730-732.
47. Kudryavtseva, N.N. (2003) Neurosci. Behav. Physiol., 33(5), 461-471.
48. Poshivalov, V.P. Leningrad: Nauka. 1986, 175p.
49. Stokes, P. and Holtz, A. (1997) Clinic. Therapeutics, 19(5), 1137-1225.
50. Rahola, J.G. (2001) Int. J Psych. Clin. Pract., 5(1), 19-28.
51. Tolstikov, A.G.; Tolstikova, G.; Sorokina I.V.; Dolgih, M.P.; Tolstikov, G.A. and Fedoseeva, L.A. The patent of the Russian Federation No62232574. Bull. SD RAMN. Medical product for treatment of various forms of depression "fluoglyzine". 2004, No20.
52. Borodin, Ju.I.; Rachkovskaya, L.N.; Darneeva, I.S. and Novoselova, T.I. Enterosorbent Noolit. For physical and psychological rehabilitation. Novosibirsk, 2006, 228 p.
53. Avgustinovich, D.F.; Kovalenko, I.L.; Sorokina, I.V.; Tolstikova, T.G. and Tolstikov, A.G. (2004) Bull. Exp. Biol. Med., 137(1), 86-89.
54. Kovalenko, I.L.; Tolstikova, T.G. and Avgustinovich, D.F. (2007) Russ. J. Physiol., 93(12), 1401-1412.
55. Kudryavtseva, N.N.; Bakshtanovskaia, I.V.; Madorskaia, I.A.; Popova, N.K.; Marona-Lewicka, D. and Vetulani, I. (1992) Korsakov' Zh Nevrol Psikhiatr 92(1), 106-109.
56. Avgustinovich, D.F.; Alekseyenko, O.V. and Koryakina, L.A. (2003) Life Sci., 72, 1437-1444.
57. Rygula, R.; Abumaria, N.; Flugge, G.; Hiemke, C.; Fuchs, E.; Ruther, E. and Havemann-Reinecke, U. (2006) Behav. Pharmacol., 17(1), 19-29.
58. Alekseenko, O.V. Features of the brain dopaminergic regulation of the experimental depression development in male mice of C57BL/6J strain. PhD. Thesis, 2001, p. 115.
59. Alekseenko, O.V.; Avgustinovich, D.F. and Lipina, T.V. (1998) I.P. Pavlov J. Higher Nerv. Activity, 48(6), 1090-1098.
60. Kudryavtseva, N.N.; Dolgov, V.V.,; Avgustinovich, D.F.; Alekseenko, O.V.; Lipina, T.V. and Koryakina L.A. (2001) Rus. J. Physiol., 87(2), 227-328.
61. Kudryavtseva, N.N.; Lipina, T.V. and Koryakina, L.A. (1999) Pharmacol. Biochem. Behav., 63(2), 229-236.
62. Lipina, T.V.; Avgustinovicb, D.F.; Koriakina, L.A.; Alekseenko, O.V. and Kudriavtseva, N.N. (1998) Exp. Clin. Pharmacol., 61(3), 13-18.
63. Kudryavtseva, N.N. and Bondar, N.P. (2002) Bull. Exp. Biol. Med., 133(4), 372-376.
64. Bondar, N.P. and Kudriavtseva, N.N. (2003) Exp. Clin. Pharmacol., 66(4), 12-16.
65. Kudryavtseva, N.N.; Gerrits, M.A.F.M.; Avgustinovich, D.F.; Tenditnik, M.V. and Van Ree, J.M. (2004) Peptides, 25, 1355-1363.
66. Kudryavtseva, N.N.; Lipina, T.V.; Vishnivetskaia, G.B. and Avgustinovich, D.F. (1996) I.P. Pavlov J. Higher Nerv. Activity, 46(2), 370-377.
67. Arregi, A.; Azpiroz, A.; Fano, E. and Garmendia, L. (2006) Aggres. Viol. Behav., 11(4), 394-413.
68. Azpiroz, A.; Garmendia, L.; Fano, E., and Sanchez-Martin, J.R. (2003) Aggres. Viol. Behav., 8(4), 433-453.
69. Blanchard, D.C. and Blanchard, R.J. (2003) Horm. Behav., 44(3), 171-177.
70. Blanchard, D.C.; Griebel, G.; and Blanchard, R.J. (2003) Eur. J. Pharmacol., 463(1-3), 97-116.
71. Blanchard, R.J.; McKittrick, C.R and Blanchard, D.C. (2001) Physiol. Behav., 73(3), 261-271.
72. Cryan, J.F.; Mombereau, C. (2004) Mol. Psychiatry, 9, 326-357.
73. Finn, D.A.; Rutledge-Gorman, M.T. and Crabbe J.C. (2003) Neurogenetics, 4(3), 109-135.
74. Haller, J. and Kruk, M.R. (2006) Neurosci. Biobehav. Rev., 30(3), 292-303.
75. Kalueff, A.V.; Wheaton, M. and Murphy, D.L. (2007) Behav. Brain Res., 179(1), 1-18.
76. Malatynska, E. and Knapp, R.J. (2005) Neurosci. Biobehav. Rev., 29(4-5), 715-737.
77. Miczek, K.A.; Faccidomo, S.D.E.; Almeida, R.M.; Bannai, M.; Fish, E.W. and Debold, J.F. (2004) Ann. N. Y. Acad Sci., 1036, 336-355.
78. Mitchell, P.J. and Redfern, P.H. (2005) Curr. Pharmaceut. Des., 11(2), 171-203.
79. Ohl, F. (2005) Handb. Exp. Pharmacol,, 169, 35-69.
80. Willner, P. (2005) Neuropsychobiology, 52(2), 90-110.
81. Borsini, F.; Podhoma,J. and Marazziti, D. (2002) Psychopharmacology, 163(2), 121-141.
82. Cryan, J.F.; Markou, A., and Lucki, I. (2002) Trends Pharmacol. Sci,, 23(5), 238-245.
83. Cryan, J.F. and Holmes, A. (2005) Nat. Rev. Drug Discov., 4(9), 775-790.
84. Berton, O. and Nestler, E.J. (2006) Nat. Rev. Neurosci., 7 (2), 137-151.
85. Keeney, A.J. and Hogg, S. (1999) Behav. Pharmacol., 8, 753-764.
86. Bartolomucci, A.; Palanza, P.; Sacerdote P.; Panerai, A.E.; Sgoifo, A.; Dantzer, R. and Parmigiani, S. (2005) Neurosci. Biobehav. Rev., 29(1), 67-81.
87. Buwalda, B.; Kole, M.H.; Veenema, A.H.; Huininga M.; de Boer S.F.; Korte S.M.; Koolhaas J.M. (2005) Neurosci. Biobehav. Rev., 29(1), 83-97.
88. Vegas, O.; Fano, E.,; Brain, P.F.; Alonso, A. and Azpiroz, A. (2006) Psychoneuroendocrinology, 31(1), 69-79.
89. Huhman K.L. (2006) Horm. Behav., 50(4), 640-646.